232 results on '"Parquet, Nathalie"'
Search Results
2. Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)
3. Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study
4. Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma
5. Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia
6. Extracorporeal Membrane Oxygenation (ECMO) during aplasia: a bridge towards myopericarditis recovery after autologous Hematopoietic Stem Cell Transplant for Systemic Sclerosis and recent Coronarovirus Disease (COVID-19) vaccination
7. Condition de réalisation de la cytaphérèse pour la mise à disposition du matériel biologique nécessaire à la production de CAR T-cells commerciaux : avis d’experts proposé par la SFGM-TC
8. Prérequis pour une production académique des cellules CART conforme aux bonnes pratiques pharmaceutiques (BPF). Recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
9. Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
10. Management of erythropoietic protoporphyria with cholestatic liver disease: A case report
11. Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC‐PM.
12. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report
13. Clinical Features and Genomic Landscape of Myeloproliferative Neoplasm (MPN) Patients with Autoimmune and Inflammatory Diseases (AID)
14. CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
15. Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study
16. Prognosis of Hyperviscosity Syndrome in Newly Diagnosed Multiple Myeloma in Modern-Era Therapy: A Real-Life Monocentric Study
17. JAK Inhibition Mediates Clonal Selection of RAS Pathway Mutations in Myeloproliferative Neoplasms
18. Distinct Clinico-Molecular Arterial and Venous Thrombotic Scoring Systems for MPN Patients Risk Stratification
19. Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim
20. Plasma exchange in the intensive care unit: Technical aspects and complications
21. Plasma exchange response in 34 patients with severe optic neuritis
22. Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma
23. Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma
24. Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathies
25. Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modernera therapy: A real-life study.
26. Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms
27. Chronic Exposure to Cytoreductive Treatment Shapes Clonal Evolution in Myeloproliferative Neoplasms
28. Genomic Landscape and Clinical Features of Myeloproliferative Neoplasm (MPN) Patients with Auto-Immune and Inflammatory Diseases (AID)
29. Myeloproliferative Neoplasms (MPN) Clonal Evolution Landscape and Its Impact on Patients' Prognosis
30. Expansion of Circulating CD49b+LAG3+ Type 1 Regulatory T Cells in Human Chronic Graft-Versus-Host Disease
31. Unresponsive thrombotic thrombocytopenic purpura in critically ill adults
32. High-dose Chemotherapy in Germ Cell Cancer Patients With Brain Metastases
33. Failure and out of Specification Manufacturing of Autologous CAR-T Cells Could be Associated with a High Concentration of Total Nucleated Cells, CD3 + Cells and Neutrophils in the Apheresis Product
34. Low Disease Burden Pre-CAR-T Cell Therapy for Children and AYA with B-ALL Is Associated with an Impaired Outcome When Obtained through Intensification of the Bridging Therapy
35. Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurements
36. Outcomes 18 months after the first human partial face transplantation
37. Erratum to: Plasma exchange response in 34 patients with severe optic neuritis
38. Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers
39. SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN)
40. NFE2 Mutations Impact AML Transformation and Overall Survival in Patients with Myeloproliferative Neoplasms (MPN)
41. Ruxolitinib Treatment Is Associated with Increased Incidence of Infections and Higher Risk of HSV/Vzv Recurrence in Patients with Myeloproliferative Neoplasm (MPN) Related Myelofibrosis (MF)
42. Interferon-Alpha (IFN) Therapy Discontinuation Is Feasible in Myeloproliferative Neoplasm (MPN) Patients with Complete Hematological Remission
43. FIRST FACE ALLOGRAFT: A THREE YEARS FOLLOW UP: O-277
44. Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients
45. Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma
46. Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience
47. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning
48. Unusual complications after bone marrow transplantation for dyskeratosis congenita
49. Short- and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation
50. KS-associated herpesvirus-like DNA sequences after allogeneic bone-marrow transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.